» Articles » PMID: 28203079

Role of Prediabetes in Stroke

Overview
Publisher Dove Medical Press
Specialty Psychiatry
Date 2017 Feb 17
PMID 28203079
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Stroke is one of the leading causes of death and probably the greatest cause of adult disability worldwide. Diabetes mellitus (DM) is a state of accelerated aging of blood vessels. Patients with diabetes have increased risk of stroke. Hyperglycemia represents a risk factor for poor outcome following stroke, and probably is just a marker of poor outcome rather than a cause. Lowering of blood glucose levels has not been shown to improve prognosis. Also, prevention of stroke risk among patients with DM is not improved with therapy for reduction of glucose levels. On the other hand, prediabetes, a metabolic state between normal glucose metabolism and diabetes, is a risk factor for the development of DM type 2 and subsequently for stroke. Several methods are known to identify prediabetes patients, including fasting plasma glucose levels, 2-hour post load glucose levels, and glycosylated hemoglobin levels. In this text, we tried to summarize known data about diagnosis, epidemiology, risk factors, pathophysiology, and prevention of prediabetes in relation to DM and stroke.

Citing Articles

Prediabetes and diabetes mellitus type II after ischemic stroke.

Moelgg K, Karisik A, Scherer L, Buergi L, Dejakum B, Komarek S Eur Stroke J. 2025; 23969873241304301.

PMID: 39763481 PMC: 11705302. DOI: 10.1177/23969873241304301.


Investigation of the role of sleep quality and sleep duration on fasting blood glucose level in acute ischemic stroke patients: A preliminary study.

Putra R, Islamiyah W Narra J. 2024; 1(3):e59.

PMID: 38450217 PMC: 10914087. DOI: 10.52225/narra.v1i3.59.


Prediabetes: An overlooked risk factor for major adverse cardiac and cerebrovascular events in atrial fibrillation patients.

Desai R, Katukuri N, Goguri S, Kothawala A, Alle N, Bellamkonda M World J Diabetes. 2024; 15(1):24-33.

PMID: 38313858 PMC: 10835500. DOI: 10.4239/wjd.v15.i1.24.


Comparative Effect of Glucose-Lowering Drugs for Type 2 Diabetes Mellitus on Stroke Prevention: A Systematic Review and Network Meta-Analysis.

Kim J, Lee G, Park K, Oh S Diabetes Metab J. 2024; 48(2):312-320.

PMID: 38273787 PMC: 10995485. DOI: 10.4093/dmj.2022.0421.


Association of Glycosylated Hemoglobin with Long-Term Adverse Cardiac Events after Percutaneous Coronary Intervention in Non Diabetes and Controlled Diabetes Patients: An Observational Study from the Korean COACT Registry.

Park H, Her S, Jung J, Chun H, Chung W Life (Basel). 2022; 12(11).

PMID: 36431080 PMC: 9699150. DOI: 10.3390/life12111945.


References
1.
De Silva D, Ebinger M, Christensen S, Parsons M, Levi C, Butcher K . Baseline diabetic status and admission blood glucose were poor prognostic factors in the EPITHET trial. Cerebrovasc Dis. 2009; 29(1):14-21. DOI: 10.1159/000255969. View

2.
Abdul-Ghani M, Tripathy D, DeFronzo R . Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care. 2006; 29(5):1130-9. DOI: 10.2337/diacare.2951130. View

3.
Kumar S, Singh R, Vasudeva N, Sharma S . Acute and chronic animal models for the evaluation of anti-diabetic agents. Cardiovasc Diabetol. 2012; 11:9. PMC: 3286385. DOI: 10.1186/1475-2840-11-9. View

4.
Harada S, Fujita-Hamabe W, Tokuyama S . Ischemic Stroke and Glucose Intolerance: a Review of the Evidence and Exploration of Novel Therapeutic Targets. J Pharmacol Sci. 2020; 118(1):1-13. DOI: 10.1254/jphs.11R04CR. View

5.
Ko G, Chan J, Woo J, Cockram C . Use of the 1997 American Diabetes Association diagnostic criteria for diabetes in a Hong Kong Chinese population. Diabetes Care. 1998; 21(12):2094-7. DOI: 10.2337/diacare.21.12.2094. View